Novel peptide–dendrimer conjugates as drug carriers for targeting nonsmall cell lung cancer
Jianfeng Liu1,2, Jinjian Liu2, Liping Chu2, Yanming Wang3, Yajun Duan1, Lina Feng2, Cuihong Yang1, Ling Wang3, Deling Kong11The Key Laboratory of Bioactive Materials, Ministry of Education, College of Life Science, Nankai University, Tianjian, People's Republic of China; 2Tianjin Key Lab...
Saved in:
Main Authors: | Liping Chu, Jinjian Liu, Jianfeng Liu, et al |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2010
|
Subjects: | |
Online Access: | https://doaj.org/article/d49dab07b98b4a788b5f38526dd0dc47 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Transferrin Conjugated pH- and Redox-Responsive Poly(Amidoamine) Dendrimer Conjugate as an Efficient Drug Delivery Carrier for Cancer Therapy
by: Hu Q, et al.
Published: (2020) -
Photosensitizer and peptide-conjugated PAMAM dendrimer for targeted in vivo photodynamic therapy
by: Narsireddy A, et al.
Published: (2015) -
Effectiveness of maintenance treatments for nonsmall cell lung cancer
by: Eadens MJ, et al.
Published: (2011) -
Enhancing cellular uptake of activable cell-penetrating peptide–doxorubicin conjugate by enzymatic cleavage
by: Shi NQ, et al.
Published: (2012) -
Randomized phase II clinical trial of chemo-immunotherapy in advanced nonsmall cell lung cancer
by: Eduardo Lasalvia-Prisco, et al.
Published: (2008)